MarketPeel
Insider Trading Intelligence
DH

David F. Hale

DRMA
DIRECTOR · DERMATA THERAPEUTICS, INC. · CIK 0001024004
FILING MIX · LIFETIME74%/26%
BUYS
17
SELLS
6
TOTAL VALUE
$0
COMPANIES
1
ACTIVE SINCE
Aug 2021
HOLDINGS NOW
2,500
AVG SELL PX
TRADE KIND
SHOWING 23 / 23
Trades · vs SPY
Loading price series…
Performance · forward returns vs SPY
2 backtested trades · 8 horizons
Forward-return performance of every backtestable P/S trade by David F. Hale, measured at 8 horizons from 7 days to 2 years. Deduped per economic event so co-filings count once. Excess return = trade return minus SPY return over the same window.
HORIZONTRADESWIN RATEINSIDER RETURNSPY RETURNMEAN EXCESSMEDIAN EXCESST-STAT
7d2+0.00%-7.06%+0.89%-7.95%-7.95%
14d2+100.00%+13.72%+1.70%+12.03%+12.03%
30d2+0.00%-17.65%+0.70%-18.35%-18.35%
60d2+0.00%-12.44%+0.73%-13.18%-13.18%
90d2+0.00%-3.14%+5.61%-8.74%-8.74%
180d2+0.00%-77.25%-0.46%-76.79%-76.79%
1y2+0.00%-85.44%-2.55%-82.89%-82.89%
2y2+0.00%-98.50%+1.28%-99.79%-99.79%
How to read this: Insider Returnis the average raw return of the filer's trades over the horizon. SPY Return is what SPY did over those same windows — reference only, not a comparison. The headline alpha number is Mean Excess = Insider − SPY; green means the filer beat SPY, red means they trailed it. Win rate is the share of individual trades where the filer beat SPY. T-statvalues above 2 mean the alpha is unlikely to be chance given the sample size. "Pending" counts trades where the horizon hasn't elapsed yet; their stats are not included in the row average.
Holdings over time
DRMA · 2,500 shares · as of Jan 2, 2026
0133,231266,463399,694532,92520222023202420252026SHARES HELD
Trading cadence · quarterly flow
BUY SELL
2021
2021
2022
2022
2022
2022
2023
2023
2023
2023
2024
2024
2024
2024
2025
2025
2025
2025
2026
FLOW · 17 buys / 6 sellsCOVERAGE · 19 quarters
Form 4 filings · all activity
COMPANYTYPESHARESPRICEVALUEHELD AFTERTRADE DATEFILEDDETAILS
DRMA
DERMATA THERAPEUTICS, INC.
PURCHASEGRANT
Stock grant
2,5002,500Jan 2, 2026Jan 6, 2026View →
DRMA
DERMATA THERAPEUTICS, INC.
PURCHASEGRANT
Stock grant
78,74180,957Jan 23, 2025Jan 23, 2025View →
DRMA
DERMATA THERAPEUTICS, INC.
PURCHASEGRANT
Stock grant
78,74178,741Jan 21, 2025Jan 23, 2025View →
DRMA
DERMATA THERAPEUTICS, INC.
PURCHASEGRANT
Stock grant
5,0005,000Jan 13, 2025Jan 14, 2025View →
DRMA
DERMATA THERAPEUTICS, INC.
PURCHASEGRANT
Stock grant
10,00010,000Jan 4, 2024Jan 5, 2024View →
DRMA
DERMATA THERAPEUTICS, INC.
PURCHASEGRANT
Stock grant
30,15575,720Oct 6, 2022Oct 7, 2022View →
DRMA
DERMATA THERAPEUTICS, INC.
PURCHASEGRANT
Stock grant
26,44145,565Jul 7, 2022Jul 8, 2022View →
DRMA
DERMATA THERAPEUTICS, INC.
PURCHASEGRANT
Stock grant
15,46619,124Apr 7, 2022Apr 8, 2022View →
DRMA
DERMATA THERAPEUTICS, INC.
PURCHASEGRANT
Stock grant
5,0005,000Jan 3, 2022Jan 5, 2022View →
DRMA
DERMATA THERAPEUTICS, INC.
PURCHASE
44,777299,411Aug 17, 2021Aug 17, 2021View →
DRMA
DERMATA THERAPEUTICS, INC.
PURCHASE
12,195311,606Aug 17, 2021Aug 17, 2021View →
DRMA
DERMATA THERAPEUTICS, INC.
PURCHASE
35,71435,714Aug 17, 2021Aug 17, 2021View →
DRMA
DERMATA THERAPEUTICS, INC.
PURCHASE
27,103532,925Aug 17, 2021Aug 17, 2021View →
DRMA
DERMATA THERAPEUTICS, INC.
PURCHASE
35,71435,714Aug 17, 2021Aug 17, 2021View →
DRMA
DERMATA THERAPEUTICS, INC.
PURCHASE
3,0483,048Aug 17, 2021Aug 17, 2021View →
DRMA
DERMATA THERAPEUTICS, INC.
SALE
250,0000Aug 17, 2021Aug 17, 2021View →
DRMA
DERMATA THERAPEUTICS, INC.
SALE
3,571,4280Aug 17, 2021Aug 17, 2021View →
DRMA
DERMATA THERAPEUTICS, INC.
SALE
410,0000Aug 17, 2021Aug 17, 2021View →
DRMA
DERMATA THERAPEUTICS, INC.
PURCHASE
20,000331,606Aug 17, 2021Aug 17, 2021View →
DRMA
DERMATA THERAPEUTICS, INC.
PURCHASE
174,216505,822Aug 17, 2021Aug 17, 2021View →
DRMA
DERMATA THERAPEUTICS, INC.
SALE
555,6220Aug 17, 2021Aug 17, 2021View →
DRMA
DERMATA THERAPEUTICS, INC.
SALE
62,5000Aug 17, 2021Aug 17, 2021View →
DRMA
DERMATA THERAPEUTICS, INC.
SALE
302,1120Aug 17, 2021Aug 17, 2021View →
Other insiders · DRMA
Loading peer insiders…
About this filer
CIK 0001024004
ROLE
Director
PRIMARY
DRMA
COMPANIES
1
ACTIVE SINCE
Aug 2021
MARKETPEEL · /INSIDER/0001024004DATA · SEC EDGAR · FORM 4 · CONSOLIDATED TAPE
FREE · DAILY · 6 AM ET

One short email. Insider buys, congressional trades, and plain-English analysis.

Feedback